IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes

Area of Science:

• Neuroimmunology
• Cellular Biology
• Molecular Biology

Background:

• Interleukin-1 receptor type I (IL-1RI) and IL-1RII mediate IL-1 signaling, with IL-1RII acting as a decoy receptor.
• Brain astrocytes are key targets of IL-1 and crucial in neuroinflammation.
• Regulation of astrocyte IL-1 receptors by anti-inflammatory cytokines like IL-4 and IL-10 is poorly understood.

Purpose of the Study:

• To investigate the regulation of IL-1RI and IL-1RII expression and function on brain astrocytes by IL-1 beta, IL-4, and IL-10.
• To elucidate the cross-talk between pro-inflammatory and anti-inflammatory cytokines on astrocyte IL-1 receptor signaling.

Main Methods:

• Reverse transcription-polymerase chain reaction (RT-PCR) to analyze mRNA expression of IL-1 receptors.
• Radioligand binding assays to quantify IL-1 receptor binding sites on astrocytes.
• Protein level analysis to assess receptor expression changes.

Main Results:

• IL-1 beta up-regulates IL-1RI and IL-1RII mRNA expression in astrocytes in a time-dependent manner.
• Astrocytes express equivalent levels of IL-1RI and IL-1RII; IL-1 beta decreases IL-1RI and increases IL-1RII binding sites.
• IL-4 and IL-10 up-regulate IL-1RII expression, while IL-4 also up-regulates IL-1RI. Both cytokines reversed IL-1 beta's inhibition of IL-1RI protein expression.

Conclusions:

• Cytokine cross-talk exists between pro-inflammatory (IL-1 beta) and anti-inflammatory (IL-4, IL-10) cytokines on brain astrocytes.
• These findings highlight a novel regulatory mechanism for IL-1 signaling in astrocytes, impacting brain inflammatory responses.